Getting Under the Skin of the Menopausal Hot Flush

NCT ID: NCT06222073

Last Updated: 2025-03-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

36 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-01-01

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this research is to 1) test how the skin blood vessels and sweat glands function in women who experience hot flushes by using skin microdialysis to deliver small amounts of substances to the skin that cause increased skin blood flow and sweating, and 2) examine the structure of the skin blood vessels and sweat glands in the skin of women who experience hot flushes by taking a very small skin biopsy. Any changes in the function or structure of the skin blood vessels or sweat glands in women with hot flushes would increase our understanding of what causes hot flushes and help to design effective treatments.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In a cross-sectional design, participants will attend the laboratory on two separate occasions. At visit 1, anthropometric measurements will be recorded and a venous blood sample will be collected to determine hormone status (e.g. oestradiol level) and pro-inflammatory markers (e.g. IL-8, Prostaglandin 2E). Participants will then undergo assessment of post-ganglionic skin blood vessel and sweat gland responsiveness (transdermal/cutaneous microdialysis). At visit 2 (\~7 days later), participants will undergo a skin punch biopsy.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Menopause

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Postmenopausal + Hot Flush (P+HF)

Postmenopausal women who regularly experience hot flushes.

No interventions assigned to this group

Postmenopausal + Hot Flush (P-HF)

Postmenopausal women who do not experience hot flushes.

No interventions assigned to this group

Premenopausal

Premenopausal women who experience regular menstruation.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged \>45 years for the postmenopausal cohort and aged 18-30 years for the premenopausal cohort
* Female
* Amenorrhoeic for \>6 months (postmenopausal criteria)
* \>4 hot flushes per day (symptomatic postmenopausal criteria)
* Eumenorrhoeic with regular menstrual cycles (premenopausal criteria)
* Healthy
* Non-smoker
* BMI 18-30 kg/m2
* No history of cardiovascular or respiratory disease
* No history of metabolic disease e.g. type II diabetes
* Drink \<14 units of alcohol per week
* Not taking any medication or treatments to alleviate hot flushes

Exclusion Criteria

* Aged \< 18 years or 31-44 years
* Male
* Smokers
* Medical history of cardiovascular/respiratory disease
* Medical history of metabolic disease e.g. type II diabetes
* Drink \>15 units of alcohol per week
* On medication or treatments to alleviate hot flushes or have taken such medication/treatment within the previous 6 months
* BMI of \<18 or \>30 kg/m2
* Vaccination (\<1 week) due to induced systemic inflammatory reaction
* Local forearm infection
* Allergy to local anaesthetic/Marcain/amide-group anaesthetics
* Pregnant
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

British Heart Foundation

OTHER

Sponsor Role collaborator

Liverpool John Moores University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kirsty A. Roberts, PhD

Role: PRINCIPAL_INVESTIGATOR

Liverpool John Moores University

David A Low, PhD

Role: PRINCIPAL_INVESTIGATOR

Liverpool John Moores University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Liverpool John Moores University

Liverpool, Merseyside, United Kingdom

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Kirsty A. Roberts, PhD

Role: CONTACT

0151 904 6244

David A Low, PhD

Role: CONTACT

0151 904 6244

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Kirsty A. Roberts, PhD

Role: primary

07780876255

David A Low, PhD

Role: backup

01519046244

References

Explore related publications, articles, or registry entries linked to this study.

Roberts KA, Doyle A, Jones H, Low DA. Getting under the skin of the menopausal hot flush: a protocol to examine skin function and structure in symptomatic postmenopausal women. Front Glob Womens Health. 2025 Aug 4;6:1514960. doi: 10.3389/fgwh.2025.1514960. eCollection 2025.

Reference Type DERIVED
PMID: 40832439 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MenoSkin

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Heat Waves and the Elderly With COPD
NCT06295523 TERMINATED NA
Heat, Microvascular Function and Aging
NCT06633198 RECRUITING EARLY_PHASE1
Heat Therapy and Peripheral Artery Disease
NCT06827691 NOT_YET_RECRUITING NA
IEEM-Heat and Heart Failure
NCT06961929 RECRUITING NA